MENA Conference University of Chicago Blood Cancer and Gene Therapy Conference 2024

Dear Colleagues,

On behalf of the Scientific and Organizing Committee, it is our great pleasure to invite you to the University of Chicago Blood Cancer and Gene Therapy Conference, which will take place on September 28th, 2024, in a hybrid format at the exquisite Rosewood Hotel, Abu Dhabi, UAE.

This conference is designed to provide a comprehensive one-day program centered around the latest advancements in Blood Cancer and Gene Therapy research, with a specific focus on Pediatrics and Adults. Renowned faculty members from the University of Chicago Medicine, alongside esteemed regional experts from the Gulf Region, will grace the occasion, ensuring the delivery of cutting-edge insights into the field of Blood Cancer and Gene Therapy. Attendees can expect to immerse themselves in a rich state-of-the-art advancements and groundbreaking discoveries.

The conference serves as an ideal platform for clinicians to engage in enlightening discussions and acquire in-depth knowledge about the latest breakthroughs in the treatment of Blood Cancer and Gene Therapy. It offers a unique opportunity to stay abreast of current challenges while exploring remarkable scientific and clinical developments in the field.

Conference Objectives
• Gain a comprehensive understanding of the latest advancements in Blood Cancer and Gene Therapy research.
• Explore the specific applications of Blood Cancer and Gene Therapy in the context of Pediatrics and Adults.
• Acquire knowledge of cutting-edge treatment modalities, techniques, and therapies in the field of Blood Cancer and Gene Therapy.
• Understand the challenges and emerging trends in the diagnosis, management, and prevention of Blood Cancer.
• Explain the latest breakthroughs in gene therapy and its potential in cancer treatment.
• Identify the role of personalized medicine and targeted therapies in the management of Blood Cancer.
• Discuss and evaluate the ethical considerations and regulatory framework surrounding gene therapy.
• Engage in interdisciplinary discussions with renowned faculty members and regional experts to foster collaboration and exchange of professional expertise.
• Enhance clinical decision-making skills by incorporating the latest research findings and evidence-based practices in Blood Cancer and Gene Therapy.
• Foster professional growth and inspire a patient-centered approach to care through exposure to passionate perspectives and innovative approaches in the field.

Conference Highlights

• Advances in targeted therapies for Blood Cancer.
• Immunotherapy approaches in Blood Cancer treatment.
• Gene editing and gene therapy techniques in the context of Blood Cancer.
• Molecular diagnostics and biomarkers for Blood Cancer.
• Precision medicine in the management of Blood Cancer.
• Updates in hematopoietic stem cell transplantation for Blood Cancer.
• Emerging trends in CAR-T cell therapy for hematologic malignancies.
• Pediatric Blood Cancer and Gene Therapy: Challenges and breakthroughs.
• Ethical considerations and regulatory frameworks in gene therapy research.
• Integrating genomic data and precision oncology in Blood Cancer treatment.

Target Audience
• Hematologists and Oncologists
• Geneticists and Genetic Counselors
• Researchers and Scientists
• Pediatricians
• Hematopathologists
• Radiologists
• Clinical Trial Investigators
• Biotechnology
• Residents and Fellows
• Physiotherapists
• Rehabilitation Specialists
• Pharmacists
• Nurses
• Healthcare Administrators and Policy Makers
• Psychologists
• Social workers
• Academics
• Patient Advocates and Support Organizations
• Regulatory Authorities and Policy Makers

+ Topics:

UCHIC-Blood-Cancer-and-Gene-Therapy-Conference-Brochure-2.pdf
Opening.mp4
Session 1.mp4
Session 2.mp4
Session 3.mp4
Session 4.mp4

* Detail:

SESSION 1 Session Chair: Dr. John Cunningham
08:00-09:00 Registration
09:00-09:15 Welcome speech Dr. Ziad Abdulhak, USA
09:15-09:30 Soft Opening – Introduction About University of Chicago Medicine Ms. Diala Atassi, USA
09:30-10:00 Official Inauguration
10:00-10:15 Cofee Break / Exhibition Visit & Networking
10:15 – 10:35 Emerging therapeutic strategies for high-risk pediatric leukemias Dr. John Cunningham, USA
10:35 – 10:55 Pediatric, Adolescent and Young Adult Fertility Preservation Dr. Lindsay Schwartz, USA
10:55 – 11:15 Stem Cell Transplantation and Gene Therapy Approaches to Sickle Cell Disease Dr. James LaBelle, USA
11:15 – 11:30 Q & A/ Panel Discussion
11:30 – 11:45 Cofee Break / Exhibition Visit & Networking

SESSION 2 Session Chair: Dr. John Cunningham
11:45-12:05 The Comprehensive Care of Adolescent Young Adult with Hematologic Malignancies Dr. Adam DuVall, USA
12:05-12:25 Hematopoietic stem cell transplantation from HLA-matched sibling donors in children. Single Centre Experience from the UAE Dr. Zainul Abideen, UAE
12:25-12:45 Expanding Horizons: Developing CAR-T Manufacturing Capabilities in New Regions Dr. Sondus AlSharidah, Kuwait
12:45-13:00 Q & A/ Panel Discussion
13:00-14:00 Lunch Break / Exhibition Visit & Networking

SESSION 3 Session Chair: Dr. Michael Bishop
14:00-14:20 The Emirati Genome Program Dr. Mohamed AlAmeri, UAE
14:20-14:40 Update of CAR T Cells and Bispecifics for Hematologic Malignancies Dr. Michael Bishop, USA
14:40-15:00 IHBD registry and role in health transformation Dr. Hatoon Ezzat, KSA
15:00-15:20 Adoptive Cell Therapy for Solid Tumors Dr. Daniel Olson, USA
15:20-15:35 Q & A/ Panel Discussion
15:35-15:50 Cofee Break / Exhibition Visit & Networking

SESSION 4 Session Chair: : Dr. Michael Bishop
15:50-16:10 Regulatory framework for In-Vivo and Ex-Vivo Gene Therapies for systemic disorders Dr. Shahrukh Hashmi, UAE
16:10-16:30 Integration of machine learning/AI into oncology (focus on head and neck cancers) Dr. Alexander Pearson, USA
16:30-16:50 Post-Transplant Care Dr. Mohammed Al Nuaimi, UAE
16:50-17:10 New treatment approaches in lymphoma Dr. Sonali Smith, USA
17:10-17:25 Q & A/ Panel discussion
17:25-17:40 Case Discussion
17:40-17:45 Closing remarks
17:45 End of Conference